Paul E. HARRINGTON

Person

Camarillo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Macrocyclic compounds that inhibit MCL-1 protein
- Patent number 11,279,712
- Issue date Mar 22, 2022
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibits MCL-1 protein
- Patent number 11,224,601
- Issue date Jan 18, 2022
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted oxazines as beta-secretase inhibitors
- Patent number 10,947,223
- Issue date Mar 16, 2021
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazine derivatives as β-secretase inhibitors and methods of use
- Patent number 10,889,579
- Issue date Jan 12, 2021
- Amgen Inc.
- Matthew P. Bourbeau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors...
- Patent number 10,889,581
- Issue date Jan 12, 2021
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit Mcl-1 protein
- Patent number 10,821,115
- Issue date Nov 3, 2020
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that inhibit Mcl-1 protein
- Patent number 10,632,128
- Issue date Apr 28, 2020
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as be...
- Patent number 9,611,261
- Issue date Apr 4, 2017
- Amgen Inc.
- Ana Elena Minatti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds a...
- Patent number 9,556,135
- Issue date Jan 31, 2017
- Amgen, Inc.
- Richard T. Lewis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhib...
- Patent number 9,550,762
- Issue date Jan 24, 2017
- Amgen, Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
- Patent number 9,096,559
- Issue date Aug 4, 2015
- Merck Sharp & Dohme Corp.
- Paul Harrington
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as be...
- Patent number 9,085,576
- Issue date Jul 21, 2015
- Amgen Inc.
- Ana Elena Minatti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
- Patent number 8,952,037
- Issue date Feb 10, 2015
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhi...
- Patent number 8,946,230
- Issue date Feb 3, 2015
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Calcium receptor modulating agents
- Patent number 8,791,147
- Issue date Jul 29, 2014
- Amgen Inc.
- Christopher Fotsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
- Patent number 8,759,532
- Issue date Jun 24, 2014
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminopyridine and carboxypyridine compounds as phosphodiesterase 10...
- Patent number 8,637,500
- Issue date Jan 28, 2014
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
- Patent number 8,389,553
- Issue date Mar 5, 2013
- Merck Sharp & Dohme Corp.
- Paul Harrington
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Calcium receptor modulating agents
- Patent number 8,349,831
- Issue date Jan 8, 2013
- Amgen Inc.
- Thomas S. Coulter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Calcium receptor modulating agents
- Patent number 8,334,317
- Issue date Dec 18, 2012
- Amgen Inc.
- Thomas S. Coulter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of urea and related diamines, methods for their manufac...
- Patent number 8,324,396
- Issue date Dec 4, 2012
- Amgen Inc.
- Pierre Deprez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
- Patent number 8,318,718
- Issue date Nov 27, 2012
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified malonate derivatives
- Patent number 8,158,825
- Issue date Apr 17, 2012
- Merck Sharp & Dohme Corp.
- Jonathan Grimm
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MACROCYCLIC COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20200247821
- Publication date Aug 6, 2020
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOPROPYL FUSED THIAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS...
- Publication number 20200231585
- Publication date Jul 23, 2020
- Amgen Inc.
- Jennifer R. ALLEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
- Publication number 20200207747
- Publication date Jul 2, 2020
- Amgen Inc.
- Jennifer R. ALLEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20200171043
- Publication date Jun 4, 2020
- Amgen Inc.
- Paul E. HARRINGTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THIAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
- Publication number 20200062743
- Publication date Feb 27, 2020
- Amgen Inc.
- Matthew P. BOURBEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20190381064
- Publication date Dec 19, 2019
- Amgen Inc.
- Paul E. HARRINGTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20180289720
- Publication date Oct 11, 2018
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIB...
- Publication number 20170267673
- Publication date Sep 21, 2017
- Amgen Inc.
- Jennifer R. ALLEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryloxycarbocyclyl Compounds as PDE 10 Inhibitors
- Publication number 20160280703
- Publication date Sep 29, 2016
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BE...
- Publication number 20160280695
- Publication date Sep 29, 2016
- Amgen Inc.
- Ana Elena Minatti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhib...
- Publication number 20160046618
- Publication date Feb 18, 2016
- Amgen Inc.
- Jennifer R. ALLEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO-DIHYDROTHIAZINE AND AMINO-DIOXIDO DIHYDROTHIAZINE COMPOUNDS A...
- Publication number 20150259308
- Publication date Sep 17, 2015
- Amgen Inc.
- Richard T. Lewis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BE...
- Publication number 20150252011
- Publication date Sep 10, 2015
- Amgen Inc.
- Ana Elena Minatti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BE...
- Publication number 20140275058
- Publication date Sep 18, 2014
- Ana Elena MINATTI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO-DIHYDROTHIAZINE AND AMINO-DIOXIDO DIHYDROTHIAZINE COMPOUNDS A...
- Publication number 20140107109
- Publication date Apr 17, 2014
- Richard T. LEWIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS
- Publication number 20130137690
- Publication date May 30, 2013
- Paul Harrington
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS
- Publication number 20130079325
- Publication date Mar 28, 2013
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYLOXYCARBOCYCLYL COMPOUNDS AS PDE10 INHIBITORS
- Publication number 20110306591
- Publication date Dec 15, 2011
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL- AND HETEROARYL- NITROGEN-HETEROCYCLIC COMPOUNDS AS PDE10 INHI...
- Publication number 20110306590
- Publication date Dec 15, 2011
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CALCIUM RECEPTOR MODULATING AGENTS
- Publication number 20110230517
- Publication date Sep 22, 2011
- Amgen Inc.
- Christopher Fotsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CALCIUM RECEPTOR MODULATING AGENTS
- Publication number 20110178133
- Publication date Jul 21, 2011
- Thomas S. Coulter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS
- Publication number 20100324046
- Publication date Dec 23, 2010
- Paul Harrington
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modified Malonate Derivatives
- Publication number 20100160327
- Publication date Jun 24, 2010
- Jonathan Grimm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 1...
- Publication number 20100160280
- Publication date Jun 24, 2010
- Amgen Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS
- Publication number 20100125062
- Publication date May 20, 2010
- AMEN INC.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Derivatives of urea and related diamines, methods for their manufac...
- Publication number 20090054463
- Publication date Feb 26, 2009
- Pierre Deprez
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Calcium receptor modulating agents
- Publication number 20080221101
- Publication date Sep 11, 2008
- Amgen Inc.
- Thomas S. Coulter
- C07 - ORGANIC CHEMISTRY

Paul E. HARRINGTON

Person

Patents Grantslast 30 patents

Macrocyclic compounds that inhibit MCL-1 protein

Compounds that inhibits MCL-1 protein

Substituted oxazines as beta-secretase inhibitors

Thiazine derivatives as β-secretase inhibitors and methods of use

Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors...

Compounds that inhibit Mcl-1 protein

Compounds that inhibit Mcl-1 protein

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as be...

Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds a...

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhib...

4-carboxybenzylamino derivatives as histone deacetylase inhibitors

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as be...

Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors

Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhi...

Calcium receptor modulating agents

Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors

Aminopyridine and carboxypyridine compounds as phosphodiesterase 10...

4-carboxybenzylamino derivatives as histone deacetylase inhibitors

Calcium receptor modulating agents

Calcium receptor modulating agents

Derivatives of urea and related diamines, methods for their manufac...

Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors

Modified malonate derivatives

Patents Applicationslast 30 patents

MACROCYCLIC COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

CYCLOPROPYL FUSED THIAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS...

OXAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

THIAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIB...

Heteroaryloxycarbocyclyl Compounds as PDE 10 Inhibitors

PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BE...

Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhib...

AMINO-DIHYDROTHIAZINE AND AMINO-DIOXIDO DIHYDROTHIAZINE COMPOUNDS A...

PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BE...

PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BE...

AMINO-DIHYDROTHIAZINE AND AMINO-DIOXIDO DIHYDROTHIAZINE COMPOUNDS A...

4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS

HETEROARYLOXYCARBOCYCLYL COMPOUNDS AS PDE10 INHIBITORS

ARYL- AND HETEROARYL- NITROGEN-HETEROCYCLIC COMPOUNDS AS PDE10 INHI...

CALCIUM RECEPTOR MODULATING AGENTS

CALCIUM RECEPTOR MODULATING AGENTS

4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

Modified Malonate Derivatives

AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 1...

PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS

Derivatives of urea and related diamines, methods for their manufac...

Calcium receptor modulating agents